How is a lung lobe removed and what is recovery like after lung cancer surgery?

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

1. 1

   The expert consensus document on minimally invasive upper lobectomy for lung cancer in China.

   Journal of thoracic disease (Wu et al.)Published Aug 24, 2026Checked Oct 13, 2026

   “Strong recommendations (grade A) advocate for video-assisted thoracoscopic surgery (VATS) or robotic-assisted thoracoscopic surgery (RATS) as the standard surgical techniques, with the requirement for systematic lymphadenectomy. Moderate recommendations (grade B) delineate optimal airway management, enhanced perioperative care protocols, and customized nodal dissection strategies. These strategies specifically differentiate between early-stage ground-glass opacity (GGO) dominant tumors and invasive carcinoma to inform selective omission of lymph node stations. Expert consensus (grade C) defines surgical indications and establishes standardized anatomical dissection sequences for upper lobectomies.ConclusionsThis consensus provides a comprehensive, evidence-based framework for the standardization of minimally invasive upper lobectomy in NSCLC. Although core surgical approaches and systematic lymphadenectomy are supported by high-level evidence, tailored nodal management and anatomical sequencing remain dependent on expert consensus, underscoring essential directions for future clinical trials.”

2. 2

   From tradition to evidence: a narrative review for standardizing chest tube management after anatomic lung resection.

   Journal of thoracic disease (Gee et al.)Published Aug 28, 2026Checked Oct 13, 2026

   “We used the Centre for Evidence-Based Medicine as a guide for grading each recommendation.Key content and findingsCurrent evidence supports the use of a single tube after lung resection, avoiding external suction, and allowing tube removal with drainage volumes of 450-500 mL/day. Digital drainage systems reduce bias in air leak assessment and variability in management decisions. Routine scheduled chest X-rays may not be necessary in the stable patient. Early chest tube removal and selected chest tube omission may be considered as safe and associated with reduced pain and hospital length of stay.ConclusionsChest tube management remains a crucial determinant in recovery after anatomic lung resection. Current evidence supports standardized ERAS-protocols which emphasize early chest tube removal, reduced imaging, and objective air leak assessment. Adoption of evidence-based guidelines on chest tube management after anatomic lung resection improve patient outcomes while simultaneously reducing practice variability.”

3. 3

   Prehabilitation and continuous perioperative rehabilitation for patients undergoing lung resection for non-small cell lung cancer: a structured narrative review.

   Journal of thoracic disease (Esakov et al.)Published Aug 28, 2026Checked Oct 13, 2026

   “The 2022 Cochrane review reported a reduced risk with preoperative exercise interventions (RR 0.45; 95% CI: 0.33 to 0.61), and a 2025 meta-analysis reported a similar association (RR 0.39; 95% CI: 0.25 to 0.60). A recent multicenter randomized trial in high-risk patients showed that a 14-day multimodal program reduced PPCs and shortened hospital stay. Functional outcomes varied according to timing, endpoint definition, baseline risk, and whether rehabilitation continued after surgery. Evidence for a sustained independent effect of the preoperative phase alone remains limited.ConclusionsPrehabilitation before lung resection for NSCLC is most consistently associated with improved early pulmonary outcomes. Continuous perioperative rehabilitation may be more relevant to sustained functional recovery than isolated preoperative intervention. A risk-adapted perioperative rehabilitation framework may be clinically useful, but should be regarded as an author-proposed approach requiring prospective validation.”

4. 4

   Quality of life during the first 3 months after uniportal vs. multiportal video-assisted thoracoscopic lobectomy for lung cancer: a prospective cohort study.

   Journal of thoracic disease (Zhang et al.)Published Aug 28, 2026Checked Oct 13, 2026

   “Longitudinal trajectories were evaluated using linear mixed-effects models in unweighted and inverse probability of treatment weighting (IPTW)-weighted analyses.ResultsAmong 130 patients, 89 underwent U-VATS and 41 underwent M-VATS. Most symptom and functioning trajectories were similar. Fear of progression showed a group-by-time interaction in both analyses; social functioning differed in the IPTW-weighted analysis, whereas constipation differed in the unweighted analysis. Compared with M-VATS, U-VATS was associated with a shorter operative time (median, 85 vs. 120 min), shorter postoperative hospital stay (median, 4 vs. 6 days), and fewer Clavien-Dindo grade ≥2 complications within 3 months (10.1% vs. 39.0%).ConclusionsMost 3-month QoL trajectories were similar after U-VATS and M-VATS lobectomy. The observed domain-specific differences were exploratory and their clinical importance remains uncertain. U-VATS was associated with more favorable unadjusted perioperative outcomes, but residual confounding precludes causal interpretation.”

5. 5

   Short-term and long-term outcomes of non-tracheal intubation anesthesia in thoracoscopic lobectomy for lung cancer: A systematic review and meta-analysis.

   Molecular and clinical oncology (Huang & Zhang)Published Jul 28, 2026Checked Oct 13, 2026

   “Total complications [odds ratio (OR)=0.53; 95% CI, 0.31 to 0.90], particularly sore throat (OR=0.18; 95% CI, 0.10 to 0.33) and pneumonia (OR=0.54; 95% CI=0.30 to 0.98) were significantly lower in the NIVATS group than in the IVATS group. Re-intubation occurred in 4.33% of NIVATS patients, while conversion to thoracotomy rates were similarly low in the NIVATS (0.69%) and IVATS (0.60%) groups. Importantly, NIVATS was associated with significantly improved overall survival [hazard ratio (HR)=0.63; 95% CI, 0.40 to 0.98] and recurrence-free survival (HR=0.62; 95% CI, 0.46 to 0.85). No significant differences were observed for anesthesia time, blood loss, hoarseness, air leakage or arrhythmia. Under the enhanced recovery after surgery framework, NIVATS appears to be a safe and technically feasible alternative to IVATS, with the potential to improve patient outcomes based on the available evidence. Its clinical adoption is supported by the evidence in the present study, offering a basis for informed decision-making.”

6. 6

   Pope diagnosed with lung cancer but had successful surgery, Vatican says

   BBC NewsPublished Oct 13, 2026Checked Oct 13, 2026

   “Pope Leo had successful surgery to remove a lower lobe of his right lung, the Vatican said.”